Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Tirzepatide is a GLP-1 receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that works on your body's appetite and blood sugar systemsit does not transfer into plasma in ways that harm recipients
As a GLP-1 receptor agonist, it effectively regulates blood sugar levels
It retains the properties of IGF-1 and is involved in cell differentiation and proliferation
Study-related adverse events Adverse reactions reported in 5% of patients and occurring more frequently with Victoza compared with placebo included nausea (21.4% vs 4.4%), vomiting (12.1% vs 2.2%), diarrhea (7.1% vs 2.9%), constipation (5.7% vs 1.5%), increased lipase (15.0% vs 8.8%), GFR decreased (6.4% vs 5.1%), and headache (5.0% vs 2.9%)
BPC-157 works best near the injection site
US$ 23.88
US$ 21.59
,aspect=ignore)
US$ 28.83
US$ 23.22
